Algert Global LLC Invitae Corp Transaction History

Algert Global LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $139,547 - $346,425	-22,221 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $89,126 - $173,826	-6,063 Reduced 21.44%	22,221 $339,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $687,584 - $950,342	28,284 New	28,284 $804,000
Q1 2020 May 13, 2020	SELL	$7.64 - $27.5 $247,444 - $890,670	-32,388 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$15.02 - $20.57 $486,467 - $666,221	32,388 New	32,388 $522,000
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $1.01 Million - $1.47 Million	-53,427 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $362,998 - $548,990	-20,898 Reduced 28.12%	53,427 $1.26 Million
Q1 2019 May 01, 2019	SELL	$10.65 - $25.75 $771,720 - $1.87 Million	-72,462 Reduced 49.37%	74,325 $1.74 Million
Q4 2018 Feb 01, 2019	BUY	$9.26 - $16.38 $588,250 - $1.04 Million	63,526 Added 76.3%	146,787 $1.62 Million
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $627,787 - $1.52 Million	83,261 New	83,261 $1.39 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.